1. Design of patient access schemes in the UK

   • Szymon Jarosławski
   • Mondher Toumi

   Short Communication 06 August 2012 Pages: 209 - 215

   

2. Cost-efficacy analysis of the MONET trial using UK antiretroviral drug prices

   • Brian Gazzard
   • Andrew Hill
   • Anne Anceau

   Short Communication 06 August 2012 Pages: 217 - 223

   

3. Ordering errors, objections and invariance in utility survey responses

   • Eve Wittenberg
   • Lisa A. Prosser

   Practical Application 06 August 2012 Pages: 225 - 241

   

4. The use of decision-analytic models in Parkinson’s disease

   • James Shearer
   • Colin Green
   • John P. Zajicek

   Review Article 06 August 2012 Pages: 243 - 258

   

5. Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis

   • Dirk Mueller
   • Afschin Gandjour

   Original Research Article 06 August 2012 Pages: 259 - 273

   

6. Drugs for rare diseases: Influence of orphan designation status on price

   • Eline Picavet
   • Marc Dooms
   • Steven Simoens

   Research Letter 06 August 2012 Pages: 275 - 279